Y Intercept Hong Kong Ltd increased its stake in medical equipment provider STERIS plc by 63.4%.

Institutional investors, including Y Intercept Hong Kong Ltd, have adjusted their stakes in medical equipment provider STERIS plc, with Y Intercept increasing its holdings by 63.4%. Despite slightly missing earnings expectations, STERIS has a "Moderate Buy" rating and a $258.75 price target. The company, valued at $21.99 billion, provides infection prevention products through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.